Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPureTech Share News (PRTC)

Share Price Information for PureTech (PRTC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 209.00
Bid: 208.00
Ask: 215.00
Change: -6.00 (-2.79%)
Spread: 7.00 (3.365%)
Open: 212.00
High: 214.00
Low: 207.00
Prev. Close: 215.00
PRTC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: FTSE 100 catches up with bank holiday rally

Tue, 29th Aug 2023 09:03

(Alliance News) - Stock prices in London opened higher on Tuesday, as UK markets return from a long bank holiday weekend and news that UK shop price inflation decelerated in August.

London's equities were also catching up with a strong European session on Monday, prompted by developments in China and well-received comments from US Federal Reserve Chair Jerome Powell on Friday.

In China, markets extended Monday's rally after China's regulators decided to slash the tax paid on stock trades for the first time since 2008.

The FTSE 100 index opened up 116.73 points, 1.6%, at 7,455.31. The FTSE 250 was up 284.59 points, 1.6%, at 18,415.61, and the AIM All-Share was up 5.96 points, 0.8%, at 739.63.

The Cboe UK 100 was up 1.4% at 742.14, the Cboe UK 250 was up 1.5% at 16,089.35, and the Cboe Small Companies was up 0.1% at 13,426.98.

In early economic news, UK shop price inflation decelerated further in August, data showed on Tuesday, presenting some "better news for consumers".

According to the latest British Retail Consortium-NielsenIQ tracker, the annual shop price inflation rate cooled to 6.9% in August from 8.4% in July. This was below the three-month average of 8.0% and the lowest rate since October 2022.

Food inflation slowed to 11.5% in August from 13.4% in July, while non-food inflation remained at 4.7%.

UK holidaymakers were also hit by travel disruption on Monday, which could last for days. Flights were cancelled leaving thousands of passengers stranded following an air traffic control technical fault.

By Monday afternoon, 232 flights departing UK airports had been cancelled and 271 arriving flights, according to aviation analytics firm Cirium.

On the back of the news, Ryanair lost 0.3% in Dublin. However, Wizz Air rose 3.1% and easyJet was up 2.0%.

The pound was quoted at USD1.2619 early on Tuesday in London, higher compared to USD1.2571 at the equities close on Friday. The euro stood at USD1.0818, up against USD1.0783. Against the yen, the dollar was trading at JPY146.43, higher compared to JPY146.27.

In the FTSE 100, Bunzl was the best performer, up 3.7%.

The London-based distribution services company reported revenue of GBP5.91 billion in the six months ended June 30, up 4.5% from GBP5.65 billion a year earlier. Pretax profit increased by 6.9% to GBP317.1 million from GBP296.6 million.

The company upped its interim dividend by 5.2% to 18.2p from 17.3p.

Also, Bunzl said it has signed an agreement to acquire a business in Poland, and also acquired a business in the Netherlands.

Rio Tinto rose 1.6%.

It said it has completed the agreement to sell a majority stake in the La Granja copper project in Peru to First Quantum Minerals, banking just over USD100 million and gaining a partner who will invest another half billion into the project.

La Granja, located high in the mountains in Cajamarca, northern Peru, is one of the largest undeveloped copper deposits in the world, Rio said. It has an indicated and inferred mineral resource totalling 4.32 billion tonnes at 0.51% copper. First Quantum will become the operator of the mine.

The agreement to sell a 55% stake in La Granja to First Quantum was first announced back in March. Rio on Tuesday said the completion follows regulatory approvals from the government of Peru, from which the Anglo-Australian miner had purchased the project back in 2006.

In the FTSE 250, PureTech Health rose 4.2%.

The US-based biotherapeutics company's pretax loss narrowed to USD13.7 million in the first half of 2023 from USD56.0 million a year earlier.

However, its revenue fell to USD3.2 million in the first half of 2023, from USD7.0 million.

Founder & Chief Executive Officer Daphne Zohar, said: "The first half of 2023 has been a strong period across both our Founded Entities and Wholly Owned Pipeline. We have achieved important clinical and financial milestones, while executing on our mission of giving life to new classes of medicine to change the lives of patients with devastating diseases."

On London's AIM, Pelatro plummeted 60%.

It said that it is seeking cancellation of trading of its shares, as it considers being listed to be no longer in the best interest of the company.

Pelatro noted the "considerable cost, management time and the legal and regulatory burden" associated with its listing.

It also said that Chief Financial Officer Nic Hellyer has resigned.

Chair Harry Berry said: "Nic has been with Pelatro since before our IPO in December 2017 and has made a significant contribution to the growth of the company since then. We wish him well for his future endeavours."

In Asia on Tuesday, the Nikkei 225 index in Tokyo closed up 0.2%. The S&P/ASX 200 in Sydney closed up 0.7%.

The Shanghai Composite closed up 1.2%, while the Hang Seng index in Hong Kong was up 1.9% in late trade. Chinese stocks extended Monday's gains after China's regulators decided to slash the tax paid on stock trades for the first time since 2008, and pledged to slow the pace of initial public offerings, which typically suck up market liquidity.

In European equities on Tuesday, the CAC 40 in Paris was up 0.2%, while the DAX 40 in Frankfurt was up 0.3%, having closed up 1.3% and 1.0% respectively on Monday.

German consumer sentiment is expected to worsen in September, according to new figures from GfK on Tuesday.

Pollster GfK said its forward-looking survey fell to minus 25.5 points in September from a revised minus 24.6 points in August. FXStreet-cited market consensus had expected the figure to come in at a slightly better minus 24.3 points.

"The consumer sentiment is currently not showing a clear trend, neither downward nor upward – and that at a very low level overall," explained Rolf Burkl, GfK consumer expert.

"The chances that consumer sentiment can sustainably recover before the end of this year are dwindling more and more. Persistently high inflation rates, especially for food and energy supplies, ensure that the consumer sentiment is currently not making any progress."

In the US on Monday, Wall Street ended higher, with the Dow Jones Industrial Average and the S&P 500 both up 0.6%, and the Nasdaq Composite up 0.8%.

It will be a data-heavy week in the US, with a gross domestic product reading on Wednesday, the Fed's preferred inflationary gauge on Thursday and the latest jobs report on Friday.

Gold was quoted at USD1,922.71 an ounce early Tuesday, higher than USD1,906.88 on Friday. Brent oil was trading at USD83.73 a barrel early Tuesday, higher than USD83.57 late Friday.

By Sophie Rose, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
18 May 2020 13:46

UK DIRECTOR DEALINGS SUMMARY: Novacyt Chair And CEO Step In To Buy

UK DIRECTOR DEALINGS SUMMARY: Novacyt Chair And CEO Step In To Buy

Read more
9 Apr 2020 12:54

PureTech Health Swings To Annual Profit On Exceptional Gains

PureTech Health Swings To Annual Profit On Exceptional Gains

Read more
9 Apr 2020 09:09

Puretech Health revenues slide, losses widen

(Sharecast News) - Clinical-stage biotherapeutics company Puretech Health posted weaker full-year revenues and a widened operating loss on Thursday and also noted it was yet to see any impact to ongoing work as a result of the Covid-19 outbreak.

Read more
2 Apr 2020 16:09

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
3 Mar 2020 16:07

PureTech Health Doses First Patient In Phase 1 LYT-100 Study

PureTech Health Doses First Patient In Phase 1 LYT-100 Study

Read more
3 Mar 2020 08:04

PureTech begins next study of lymphoedema drug candidate

(Sharecast News) - Clinical-stage biotherapeutics company PureTech Health announced on Tuesday that the first participant has been dosed in a clinical study of 'LYT-100', its wholly-owned product candidate for the potential treatment of lymphoedema and other fibrotic conditions.

Read more
25 Feb 2020 14:10

PureTech Health Affiliate Akili Posts Encouraging ADHD Study Results

PureTech Health Affiliate Akili Posts Encouraging ADHD Study Results

Read more
24 Jan 2020 12:45

Friday broker round-up

(Sharecast News) - TT Electronics: Jefferies downgrades to hold with a target price of 265p.

Read more
23 Jan 2020 07:44

PureTech sells shares in Karuna affiliate for $200m

(Sharecast News) - Clinical stage biotech company PureTech Health said it had sold 2.1m shares of its affiliate Karuna Therapeutics for $200m.

Read more
15 Jan 2020 13:26

PureTech Health Unit Akili's AKL-T01 Study Achieves Primary Endpoint

PureTech Health Unit Akili's AKL-T01 Study Achieves Primary Endpoint

Read more
19 Dec 2019 17:33

PureTech Health Affiliate Reports Positive Results In Alopecia Study

PureTech Health Affiliate Reports Positive Results In Alopecia Study

Read more
19 Dec 2019 08:25

PureTech affiliate Follica reports 44% improvement in hair-loss study

(Sharecast News) - PureTech Health on Thursday said results from a study into a hair loss treatment developed by its affiliate Follica demonstrated a statistically significant 44% improvement in hair count.

Read more
17 Dec 2019 16:13

PureTech's Gelesis Partners With Telehealth Firm Ro For Plenity In US

PureTech's Gelesis Partners With Telehealth Firm Ro For Plenity In US

Read more
12 Dec 2019 15:52

PureTech Health Investee Akili Delivers Positive AKL-T03 Trial Results

PureTech Health Investee Akili Delivers Positive AKL-T03 Trial Results

Read more
10 Dec 2019 14:47

PureTech Health's Vedanta Launches First-In-Patient Study Of VE800

PureTech Health's Vedanta Launches First-In-Patient Study Of VE800

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.